NGL Fine-Chem Limited — PPTs, 11-11-2024: Investor Presentation

NGL Fine-Chem Limited reported Q2 and H1 results in line with guidance, showing modest growth amid challenging market conditions due to soft European demand and geopolitical tensions. A strong recovery from China positively impacted overall performance, and the company gained a new product certification. Financial highlights included revenue growth of 3.01% QoQ and 16.6% YoY, with EBITDA margins facing pressure. NGL is advancing capital expenditure initiatives and aims for operational resilience despite market hurdles.